Market Cap

Healius Limited Market Capitalization:

A$1.03 Billion

AUD as of July 1, 2024

US$686.7 Million

business Healius Limited Company Profile

Healius Limited Main Stock Listing

ASX: HLS

Market Capitalization History of Healius Limited

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Medical Care Facilities
Company Market Cap (USD)
HCA Healthcare, Inc. $110.07 B
Fresenius SE & Co KGaA $31.58 B
Dr. Sulaiman Al Habib Medical Services Group Company $23.99 B
JD Health International, Inc. $23.26 B
Tenet Healthcare Corporation $17.62 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $968.50 B
Johnson & Johnson $499.57 B
AbbVie $405.28 B
Roche $332.12 B
UnitedHealth Group $304.72 B

Yearly evolution of Healius Limited market cap

Date Market Cap YoY Change
Jan. 1, 2024 A$1.10 B -39.11%
Jan. 1, 2023 A$1.80 B -27.48%
Jan. 1, 2022 A$2.48 B 10.72%
Jan. 31, 2021 A$2.24 B 2.30%
Jan. 1, 2021 A$2.19 B 28.95%
Jan. 31, 2020 A$1.70 B 2.70%
Jan. 1, 2020 A$1.66 B 6.47%
Jan. 31, 2019 A$1.55 B -5.12%
Jan. 1, 2019 A$1.64 B -24.08%
Jan. 31, 2018 A$2.16 B 8.11%
Jan. 1, 2018 A$2.00 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Company Description

Healius Limited is a health care company managing ambulatory care centers, laboratories, medical imaging centers, day hospitals and fertility treatments facilities. It operates more than 2000 pathology diagnostic facilities, 15 day hospitals, and 130 imaging centers across Australia.

business Healius Limited Company Profile

Healius Limited Categories

Australia languages Healthcare languages Medical Care Facilities
Australia Healthcare Australia Medical Care Facilities

Stocks & Indices

Healius Limited has the following listings and related stock indices.


Stock: ASX: HLS

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.